Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease
Open Access
- 12 July 2006
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 24 (3) , 553-559
Abstract
Summary: Backgound: In coeliac disease, following the introduction of a gluten‐free diet, monitoring mucosal disease activity requires repeated small intestinal biopsies. If a test measuring a circulating inflammatory marker was available, this would be clinically valuable.Aim: To determine if levels of soluble CD163, a scavenger receptor shed by tissue macrophages, correlated with the inflammatory lesion in coeliac disease.Methods: Serum samples were collected from 131 patients with untreated coeliac disease, 40 patients with treated coeliac disease, 92 non‐coeliac disease control subjects and 131 healthy controls. A capture enzyme linked immunosorbance assay was established to measure levels of soluble CD163 in sera. The extent of the histological lesion in coeliac biopsies was assessed using a Marsh grading system.Results: Levels of CD163 in untreated coeliac subjects were significantly elevated when compared with the treated coeliac patients, the disease control group and the healthy control subjects (P < 0.0001 in each instance). Moreover, coeliac patients with the most marked histological lesion (Marsh 3) had significantly higher levels of soluble CD163 than patients with Marsh grade 2 lesions (P < 0.0004), with grade 1 lesions (P < 0.0001) and grade 0 lesions (P < 0.0001).Conclusions: Measurement of soluble CD163 may be a useful method of monitoring the inflammatory lesion in coeliac disease.Keywords
This publication has 34 references indexed in Scilit:
- The macrophage scavenger receptor CD163Immunobiology, 2005
- Duodenal histology in patients with celiac disease after treatment with a gluten-free dietGastrointestinal Endoscopy, 2003
- Histologic Follow-up of People With Celiac Disease on a Gluten-Free DietAmerican Journal of Clinical Pathology, 2002
- Identification of the haemoglobin scavenger receptorNature, 2001
- Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphomaThe Lancet, 2000
- Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recoveryAmerican Journal of Gastroenterology, 2000
- Fortnightly review: Coeliac diseaseBMJ, 1999
- Reliability of Immunologic Markers of Celiac Sprue in the Assessment of Mucosal Recovery After Gluten WithdrawalJournal of Clinical Gastroenterology, 1996
- Gluten, major histocompatibility complex, and the small intestineGastroenterology, 1992
- Mucosal and systemic IgA anti-gliadin antibody in celiac diseaseDigestive Diseases and Sciences, 1991